Drug Type Chemical drugs |
Synonyms Sygen, AGF2, GM1 |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC73H129N3O30 |
InChIKeyWVHBJHLTCHODOA-UHFFFAOYSA-N |
CAS Registry100345-64-0 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Chemotherapy-Induced Febrile Neutropenia | Phase 3 | CN | - | 01 Sep 2014 |
Colorectal Cancer | Phase 3 | CN | - | 01 Sep 2014 |
Neurotoxicity Syndromes | Phase 3 | CN | - | 01 Sep 2014 |
Alzheimer Disease | Phase 1 | - | - | |
Parkinson Disease | Phase 1 | - | - | |
Spinal Cord Injuries | Phase 1 | - | - | |
Stroke | Phase 1 | - | - |